Medical Care
Global Long-Acting Injectable (LAI) Antipsychotic Market Research Report 2025
- May 05, 25
- ID: 226839
- Pages: 73
- Figures: 80
- Views: 42
The global market for Long-Acting Injectable (LAI) Antipsychotic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Long-acting injectable (LAI) antipsychotics are a pharmacologic strategy for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Long-Acting Injectable (LAI) Antipsychotic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-Acting Injectable (LAI) Antipsychotic.
The Long-Acting Injectable (LAI) Antipsychotic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Long-Acting Injectable (LAI) Antipsychotic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long-Acting Injectable (LAI) Antipsychotic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alkermes
Eli Lilly and Company
Janssen Global Services, LLC
Abilify Maintena
Haldol
Otsuka Pharmaceutical
Aristada
Prolixin
Sumitomo Dainippon Pharma
Segment by Type
Aripiprazole
Fluphenazine
Haloperidol
Others
Segment by Application
Hospital
Retail Pharmacy
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Long-Acting Injectable (LAI) Antipsychotic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Long-acting injectable (LAI) antipsychotics are a pharmacologic strategy for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Long-Acting Injectable (LAI) Antipsychotic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-Acting Injectable (LAI) Antipsychotic.
The Long-Acting Injectable (LAI) Antipsychotic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Long-Acting Injectable (LAI) Antipsychotic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long-Acting Injectable (LAI) Antipsychotic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alkermes
Eli Lilly and Company
Janssen Global Services, LLC
Abilify Maintena
Haldol
Otsuka Pharmaceutical
Aristada
Prolixin
Sumitomo Dainippon Pharma
Segment by Type
Aripiprazole
Fluphenazine
Haloperidol
Others
Segment by Application
Hospital
Retail Pharmacy
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Long-Acting Injectable (LAI) Antipsychotic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Aripiprazole
1.2.3 Fluphenazine
1.2.4 Haloperidol
1.2.5 Others
1.3 Market by Application
1.3.1 Global Long-Acting Injectable (LAI) Antipsychotic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Long-Acting Injectable (LAI) Antipsychotic Market Perspective (2020-2031)
2.2 Global Long-Acting Injectable (LAI) Antipsychotic Growth Trends by Region
2.2.1 Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Long-Acting Injectable (LAI) Antipsychotic Historic Market Size by Region (2020-2025)
2.2.3 Long-Acting Injectable (LAI) Antipsychotic Forecasted Market Size by Region (2026-2031)
2.3 Long-Acting Injectable (LAI) Antipsychotic Market Dynamics
2.3.1 Long-Acting Injectable (LAI) Antipsychotic Industry Trends
2.3.2 Long-Acting Injectable (LAI) Antipsychotic Market Drivers
2.3.3 Long-Acting Injectable (LAI) Antipsychotic Market Challenges
2.3.4 Long-Acting Injectable (LAI) Antipsychotic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long-Acting Injectable (LAI) Antipsychotic Players by Revenue
3.1.1 Global Top Long-Acting Injectable (LAI) Antipsychotic Players by Revenue (2020-2025)
3.1.2 Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Players (2020-2025)
3.2 Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Long-Acting Injectable (LAI) Antipsychotic Revenue
3.4 Global Long-Acting Injectable (LAI) Antipsychotic Market Concentration Ratio
3.4.1 Global Long-Acting Injectable (LAI) Antipsychotic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long-Acting Injectable (LAI) Antipsychotic Revenue in 2024
3.5 Global Key Players of Long-Acting Injectable (LAI) Antipsychotic Head office and Area Served
3.6 Global Key Players of Long-Acting Injectable (LAI) Antipsychotic, Product and Application
3.7 Global Key Players of Long-Acting Injectable (LAI) Antipsychotic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Long-Acting Injectable (LAI) Antipsychotic Breakdown Data by Type
4.1 Global Long-Acting Injectable (LAI) Antipsychotic Historic Market Size by Type (2020-2025)
4.2 Global Long-Acting Injectable (LAI) Antipsychotic Forecasted Market Size by Type (2026-2031)
5 Long-Acting Injectable (LAI) Antipsychotic Breakdown Data by Application
5.1 Global Long-Acting Injectable (LAI) Antipsychotic Historic Market Size by Application (2020-2025)
5.2 Global Long-Acting Injectable (LAI) Antipsychotic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Long-Acting Injectable (LAI) Antipsychotic Market Size (2020-2031)
6.2 North America Long-Acting Injectable (LAI) Antipsychotic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025)
6.4 North America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size (2020-2031)
7.2 Europe Long-Acting Injectable (LAI) Antipsychotic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025)
7.4 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size (2020-2031)
8.2 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2020-2025)
8.4 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size (2020-2031)
9.2 Latin America Long-Acting Injectable (LAI) Antipsychotic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025)
9.4 Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size (2020-2031)
10.2 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025)
10.4 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alkermes
11.1.1 Alkermes Company Details
11.1.2 Alkermes Business Overview
11.1.3 Alkermes Long-Acting Injectable (LAI) Antipsychotic Introduction
11.1.4 Alkermes Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
11.1.5 Alkermes Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Introduction
11.2.4 Eli Lilly and Company Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
11.2.5 Eli Lilly and Company Recent Development
11.3 Janssen Global Services, LLC
11.3.1 Janssen Global Services, LLC Company Details
11.3.2 Janssen Global Services, LLC Business Overview
11.3.3 Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Introduction
11.3.4 Janssen Global Services, LLC Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
11.3.5 Janssen Global Services, LLC Recent Development
11.4 Abilify Maintena
11.4.1 Abilify Maintena Company Details
11.4.2 Abilify Maintena Business Overview
11.4.3 Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Introduction
11.4.4 Abilify Maintena Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
11.4.5 Abilify Maintena Recent Development
11.5 Haldol
11.5.1 Haldol Company Details
11.5.2 Haldol Business Overview
11.5.3 Haldol Long-Acting Injectable (LAI) Antipsychotic Introduction
11.5.4 Haldol Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
11.5.5 Haldol Recent Development
11.6 Otsuka Pharmaceutical
11.6.1 Otsuka Pharmaceutical Company Details
11.6.2 Otsuka Pharmaceutical Business Overview
11.6.3 Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Introduction
11.6.4 Otsuka Pharmaceutical Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
11.6.5 Otsuka Pharmaceutical Recent Development
11.7 Aristada
11.7.1 Aristada Company Details
11.7.2 Aristada Business Overview
11.7.3 Aristada Long-Acting Injectable (LAI) Antipsychotic Introduction
11.7.4 Aristada Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
11.7.5 Aristada Recent Development
11.8 Prolixin
11.8.1 Prolixin Company Details
11.8.2 Prolixin Business Overview
11.8.3 Prolixin Long-Acting Injectable (LAI) Antipsychotic Introduction
11.8.4 Prolixin Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
11.8.5 Prolixin Recent Development
11.9 Sumitomo Dainippon Pharma
11.9.1 Sumitomo Dainippon Pharma Company Details
11.9.2 Sumitomo Dainippon Pharma Business Overview
11.9.3 Sumitomo Dainippon Pharma Long-Acting Injectable (LAI) Antipsychotic Introduction
11.9.4 Sumitomo Dainippon Pharma Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
11.9.5 Sumitomo Dainippon Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Aripiprazole
1.2.3 Fluphenazine
1.2.4 Haloperidol
1.2.5 Others
1.3 Market by Application
1.3.1 Global Long-Acting Injectable (LAI) Antipsychotic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Long-Acting Injectable (LAI) Antipsychotic Market Perspective (2020-2031)
2.2 Global Long-Acting Injectable (LAI) Antipsychotic Growth Trends by Region
2.2.1 Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Long-Acting Injectable (LAI) Antipsychotic Historic Market Size by Region (2020-2025)
2.2.3 Long-Acting Injectable (LAI) Antipsychotic Forecasted Market Size by Region (2026-2031)
2.3 Long-Acting Injectable (LAI) Antipsychotic Market Dynamics
2.3.1 Long-Acting Injectable (LAI) Antipsychotic Industry Trends
2.3.2 Long-Acting Injectable (LAI) Antipsychotic Market Drivers
2.3.3 Long-Acting Injectable (LAI) Antipsychotic Market Challenges
2.3.4 Long-Acting Injectable (LAI) Antipsychotic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long-Acting Injectable (LAI) Antipsychotic Players by Revenue
3.1.1 Global Top Long-Acting Injectable (LAI) Antipsychotic Players by Revenue (2020-2025)
3.1.2 Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Players (2020-2025)
3.2 Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Long-Acting Injectable (LAI) Antipsychotic Revenue
3.4 Global Long-Acting Injectable (LAI) Antipsychotic Market Concentration Ratio
3.4.1 Global Long-Acting Injectable (LAI) Antipsychotic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long-Acting Injectable (LAI) Antipsychotic Revenue in 2024
3.5 Global Key Players of Long-Acting Injectable (LAI) Antipsychotic Head office and Area Served
3.6 Global Key Players of Long-Acting Injectable (LAI) Antipsychotic, Product and Application
3.7 Global Key Players of Long-Acting Injectable (LAI) Antipsychotic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Long-Acting Injectable (LAI) Antipsychotic Breakdown Data by Type
4.1 Global Long-Acting Injectable (LAI) Antipsychotic Historic Market Size by Type (2020-2025)
4.2 Global Long-Acting Injectable (LAI) Antipsychotic Forecasted Market Size by Type (2026-2031)
5 Long-Acting Injectable (LAI) Antipsychotic Breakdown Data by Application
5.1 Global Long-Acting Injectable (LAI) Antipsychotic Historic Market Size by Application (2020-2025)
5.2 Global Long-Acting Injectable (LAI) Antipsychotic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Long-Acting Injectable (LAI) Antipsychotic Market Size (2020-2031)
6.2 North America Long-Acting Injectable (LAI) Antipsychotic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025)
6.4 North America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size (2020-2031)
7.2 Europe Long-Acting Injectable (LAI) Antipsychotic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025)
7.4 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size (2020-2031)
8.2 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2020-2025)
8.4 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size (2020-2031)
9.2 Latin America Long-Acting Injectable (LAI) Antipsychotic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025)
9.4 Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size (2020-2031)
10.2 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025)
10.4 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alkermes
11.1.1 Alkermes Company Details
11.1.2 Alkermes Business Overview
11.1.3 Alkermes Long-Acting Injectable (LAI) Antipsychotic Introduction
11.1.4 Alkermes Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
11.1.5 Alkermes Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Introduction
11.2.4 Eli Lilly and Company Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
11.2.5 Eli Lilly and Company Recent Development
11.3 Janssen Global Services, LLC
11.3.1 Janssen Global Services, LLC Company Details
11.3.2 Janssen Global Services, LLC Business Overview
11.3.3 Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Introduction
11.3.4 Janssen Global Services, LLC Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
11.3.5 Janssen Global Services, LLC Recent Development
11.4 Abilify Maintena
11.4.1 Abilify Maintena Company Details
11.4.2 Abilify Maintena Business Overview
11.4.3 Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Introduction
11.4.4 Abilify Maintena Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
11.4.5 Abilify Maintena Recent Development
11.5 Haldol
11.5.1 Haldol Company Details
11.5.2 Haldol Business Overview
11.5.3 Haldol Long-Acting Injectable (LAI) Antipsychotic Introduction
11.5.4 Haldol Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
11.5.5 Haldol Recent Development
11.6 Otsuka Pharmaceutical
11.6.1 Otsuka Pharmaceutical Company Details
11.6.2 Otsuka Pharmaceutical Business Overview
11.6.3 Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Introduction
11.6.4 Otsuka Pharmaceutical Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
11.6.5 Otsuka Pharmaceutical Recent Development
11.7 Aristada
11.7.1 Aristada Company Details
11.7.2 Aristada Business Overview
11.7.3 Aristada Long-Acting Injectable (LAI) Antipsychotic Introduction
11.7.4 Aristada Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
11.7.5 Aristada Recent Development
11.8 Prolixin
11.8.1 Prolixin Company Details
11.8.2 Prolixin Business Overview
11.8.3 Prolixin Long-Acting Injectable (LAI) Antipsychotic Introduction
11.8.4 Prolixin Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
11.8.5 Prolixin Recent Development
11.9 Sumitomo Dainippon Pharma
11.9.1 Sumitomo Dainippon Pharma Company Details
11.9.2 Sumitomo Dainippon Pharma Business Overview
11.9.3 Sumitomo Dainippon Pharma Long-Acting Injectable (LAI) Antipsychotic Introduction
11.9.4 Sumitomo Dainippon Pharma Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
11.9.5 Sumitomo Dainippon Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Aripiprazole
Table 3. Key Players of Fluphenazine
Table 4. Key Players of Haloperidol
Table 5. Key Players of Others
Table 6. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Region (2020-2025)
Table 10. Global Long-Acting Injectable (LAI) Antipsychotic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Region (2026-2031)
Table 12. Long-Acting Injectable (LAI) Antipsychotic Market Trends
Table 13. Long-Acting Injectable (LAI) Antipsychotic Market Drivers
Table 14. Long-Acting Injectable (LAI) Antipsychotic Market Challenges
Table 15. Long-Acting Injectable (LAI) Antipsychotic Market Restraints
Table 16. Global Long-Acting Injectable (LAI) Antipsychotic Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Players (2020-2025)
Table 18. Global Top Long-Acting Injectable (LAI) Antipsychotic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Injectable (LAI) Antipsychotic as of 2024)
Table 19. Ranking of Global Top Long-Acting Injectable (LAI) Antipsychotic Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Long-Acting Injectable (LAI) Antipsychotic Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Long-Acting Injectable (LAI) Antipsychotic, Headquarters and Area Served
Table 22. Global Key Players of Long-Acting Injectable (LAI) Antipsychotic, Product and Application
Table 23. Global Key Players of Long-Acting Injectable (LAI) Antipsychotic, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Type (2020-2025)
Table 27. Global Long-Acting Injectable (LAI) Antipsychotic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Type (2026-2031)
Table 29. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Application (2020-2025)
Table 31. Global Long-Acting Injectable (LAI) Antipsychotic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Application (2026-2031)
Table 33. North America Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031) & (US$ Million)
Table 48. Alkermes Company Details
Table 49. Alkermes Business Overview
Table 50. Alkermes Long-Acting Injectable (LAI) Antipsychotic Product
Table 51. Alkermes Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)
Table 52. Alkermes Recent Development
Table 53. Eli Lilly and Company Company Details
Table 54. Eli Lilly and Company Business Overview
Table 55. Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Product
Table 56. Eli Lilly and Company Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)
Table 57. Eli Lilly and Company Recent Development
Table 58. Janssen Global Services, LLC Company Details
Table 59. Janssen Global Services, LLC Business Overview
Table 60. Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Product
Table 61. Janssen Global Services, LLC Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)
Table 62. Janssen Global Services, LLC Recent Development
Table 63. Abilify Maintena Company Details
Table 64. Abilify Maintena Business Overview
Table 65. Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Product
Table 66. Abilify Maintena Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)
Table 67. Abilify Maintena Recent Development
Table 68. Haldol Company Details
Table 69. Haldol Business Overview
Table 70. Haldol Long-Acting Injectable (LAI) Antipsychotic Product
Table 71. Haldol Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)
Table 72. Haldol Recent Development
Table 73. Otsuka Pharmaceutical Company Details
Table 74. Otsuka Pharmaceutical Business Overview
Table 75. Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Product
Table 76. Otsuka Pharmaceutical Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)
Table 77. Otsuka Pharmaceutical Recent Development
Table 78. Aristada Company Details
Table 79. Aristada Business Overview
Table 80. Aristada Long-Acting Injectable (LAI) Antipsychotic Product
Table 81. Aristada Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)
Table 82. Aristada Recent Development
Table 83. Prolixin Company Details
Table 84. Prolixin Business Overview
Table 85. Prolixin Long-Acting Injectable (LAI) Antipsychotic Product
Table 86. Prolixin Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)
Table 87. Prolixin Recent Development
Table 88. Sumitomo Dainippon Pharma Company Details
Table 89. Sumitomo Dainippon Pharma Business Overview
Table 90. Sumitomo Dainippon Pharma Long-Acting Injectable (LAI) Antipsychotic Product
Table 91. Sumitomo Dainippon Pharma Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)
Table 92. Sumitomo Dainippon Pharma Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Long-Acting Injectable (LAI) Antipsychotic Picture
Figure 2. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Type: 2024 VS 2031
Figure 4. Aripiprazole Features
Figure 5. Fluphenazine Features
Figure 6. Haloperidol Features
Figure 7. Others Features
Figure 8. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Others Case Studies
Figure 13. Long-Acting Injectable (LAI) Antipsychotic Report Years Considered
Figure 14. Global Long-Acting Injectable (LAI) Antipsychotic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Long-Acting Injectable (LAI) Antipsychotic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Region: 2024 VS 2031
Figure 17. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Players in 2024
Figure 18. Global Top Long-Acting Injectable (LAI) Antipsychotic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Injectable (LAI) Antipsychotic as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Long-Acting Injectable (LAI) Antipsychotic Revenue in 2024
Figure 20. North America Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Long-Acting Injectable (LAI) Antipsychotic Market Share by Country (2020-2031)
Figure 22. United States Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Long-Acting Injectable (LAI) Antipsychotic Market Share by Country (2020-2031)
Figure 26. Germany Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Share by Region (2020-2031)
Figure 34. China Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Long-Acting Injectable (LAI) Antipsychotic Market Share by Country (2020-2031)
Figure 42. Mexico Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Share by Country (2020-2031)
Figure 46. Turkey Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Alkermes Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
Figure 50. Eli Lilly and Company Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
Figure 51. Janssen Global Services, LLC Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
Figure 52. Abilify Maintena Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
Figure 53. Haldol Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
Figure 54. Otsuka Pharmaceutical Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
Figure 55. Aristada Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
Figure 56. Prolixin Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
Figure 57. Sumitomo Dainippon Pharma Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Aripiprazole
Table 3. Key Players of Fluphenazine
Table 4. Key Players of Haloperidol
Table 5. Key Players of Others
Table 6. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Region (2020-2025)
Table 10. Global Long-Acting Injectable (LAI) Antipsychotic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Region (2026-2031)
Table 12. Long-Acting Injectable (LAI) Antipsychotic Market Trends
Table 13. Long-Acting Injectable (LAI) Antipsychotic Market Drivers
Table 14. Long-Acting Injectable (LAI) Antipsychotic Market Challenges
Table 15. Long-Acting Injectable (LAI) Antipsychotic Market Restraints
Table 16. Global Long-Acting Injectable (LAI) Antipsychotic Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Players (2020-2025)
Table 18. Global Top Long-Acting Injectable (LAI) Antipsychotic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Injectable (LAI) Antipsychotic as of 2024)
Table 19. Ranking of Global Top Long-Acting Injectable (LAI) Antipsychotic Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Long-Acting Injectable (LAI) Antipsychotic Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Long-Acting Injectable (LAI) Antipsychotic, Headquarters and Area Served
Table 22. Global Key Players of Long-Acting Injectable (LAI) Antipsychotic, Product and Application
Table 23. Global Key Players of Long-Acting Injectable (LAI) Antipsychotic, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Type (2020-2025)
Table 27. Global Long-Acting Injectable (LAI) Antipsychotic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Type (2026-2031)
Table 29. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Application (2020-2025)
Table 31. Global Long-Acting Injectable (LAI) Antipsychotic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Application (2026-2031)
Table 33. North America Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2026-2031) & (US$ Million)
Table 48. Alkermes Company Details
Table 49. Alkermes Business Overview
Table 50. Alkermes Long-Acting Injectable (LAI) Antipsychotic Product
Table 51. Alkermes Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)
Table 52. Alkermes Recent Development
Table 53. Eli Lilly and Company Company Details
Table 54. Eli Lilly and Company Business Overview
Table 55. Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Product
Table 56. Eli Lilly and Company Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)
Table 57. Eli Lilly and Company Recent Development
Table 58. Janssen Global Services, LLC Company Details
Table 59. Janssen Global Services, LLC Business Overview
Table 60. Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Product
Table 61. Janssen Global Services, LLC Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)
Table 62. Janssen Global Services, LLC Recent Development
Table 63. Abilify Maintena Company Details
Table 64. Abilify Maintena Business Overview
Table 65. Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Product
Table 66. Abilify Maintena Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)
Table 67. Abilify Maintena Recent Development
Table 68. Haldol Company Details
Table 69. Haldol Business Overview
Table 70. Haldol Long-Acting Injectable (LAI) Antipsychotic Product
Table 71. Haldol Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)
Table 72. Haldol Recent Development
Table 73. Otsuka Pharmaceutical Company Details
Table 74. Otsuka Pharmaceutical Business Overview
Table 75. Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Product
Table 76. Otsuka Pharmaceutical Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)
Table 77. Otsuka Pharmaceutical Recent Development
Table 78. Aristada Company Details
Table 79. Aristada Business Overview
Table 80. Aristada Long-Acting Injectable (LAI) Antipsychotic Product
Table 81. Aristada Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)
Table 82. Aristada Recent Development
Table 83. Prolixin Company Details
Table 84. Prolixin Business Overview
Table 85. Prolixin Long-Acting Injectable (LAI) Antipsychotic Product
Table 86. Prolixin Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)
Table 87. Prolixin Recent Development
Table 88. Sumitomo Dainippon Pharma Company Details
Table 89. Sumitomo Dainippon Pharma Business Overview
Table 90. Sumitomo Dainippon Pharma Long-Acting Injectable (LAI) Antipsychotic Product
Table 91. Sumitomo Dainippon Pharma Revenue in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025) & (US$ Million)
Table 92. Sumitomo Dainippon Pharma Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Long-Acting Injectable (LAI) Antipsychotic Picture
Figure 2. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Type: 2024 VS 2031
Figure 4. Aripiprazole Features
Figure 5. Fluphenazine Features
Figure 6. Haloperidol Features
Figure 7. Others Features
Figure 8. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Others Case Studies
Figure 13. Long-Acting Injectable (LAI) Antipsychotic Report Years Considered
Figure 14. Global Long-Acting Injectable (LAI) Antipsychotic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Long-Acting Injectable (LAI) Antipsychotic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Region: 2024 VS 2031
Figure 17. Global Long-Acting Injectable (LAI) Antipsychotic Market Share by Players in 2024
Figure 18. Global Top Long-Acting Injectable (LAI) Antipsychotic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Injectable (LAI) Antipsychotic as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Long-Acting Injectable (LAI) Antipsychotic Revenue in 2024
Figure 20. North America Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Long-Acting Injectable (LAI) Antipsychotic Market Share by Country (2020-2031)
Figure 22. United States Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Long-Acting Injectable (LAI) Antipsychotic Market Share by Country (2020-2031)
Figure 26. Germany Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Share by Region (2020-2031)
Figure 34. China Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Long-Acting Injectable (LAI) Antipsychotic Market Share by Country (2020-2031)
Figure 42. Mexico Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Share by Country (2020-2031)
Figure 46. Turkey Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Long-Acting Injectable (LAI) Antipsychotic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Alkermes Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
Figure 50. Eli Lilly and Company Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
Figure 51. Janssen Global Services, LLC Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
Figure 52. Abilify Maintena Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
Figure 53. Haldol Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
Figure 54. Otsuka Pharmaceutical Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
Figure 55. Aristada Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
Figure 56. Prolixin Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
Figure 57. Sumitomo Dainippon Pharma Revenue Growth Rate in Long-Acting Injectable (LAI) Antipsychotic Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232